PE20061137A1 - Compuestos derivados de macrolidos amino sustituidas - Google Patents

Compuestos derivados de macrolidos amino sustituidas

Info

Publication number
PE20061137A1
PE20061137A1 PE2005001311A PE2005001311A PE20061137A1 PE 20061137 A1 PE20061137 A1 PE 20061137A1 PE 2005001311 A PE2005001311 A PE 2005001311A PE 2005001311 A PE2005001311 A PE 2005001311A PE 20061137 A1 PE20061137 A1 PE 20061137A1
Authority
PE
Peru
Prior art keywords
morocco
quinolinyl
dihydro
oxo
carboxy
Prior art date
Application number
PE2005001311A
Other languages
English (en)
Spanish (es)
Inventor
Desmond John Best
Andrew Keith Forrest
Andrea Fajdetic
Robert John Sheppard
John Stephen Elder
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of PE20061137A1 publication Critical patent/PE20061137A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PE2005001311A 2004-11-11 2005-11-09 Compuestos derivados de macrolidos amino sustituidas PE20061137A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424959A GB0424959D0 (en) 2004-11-11 2004-11-11 Novel compounds

Publications (1)

Publication Number Publication Date
PE20061137A1 true PE20061137A1 (es) 2006-12-13

Family

ID=33523587

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001311A PE20061137A1 (es) 2004-11-11 2005-11-09 Compuestos derivados de macrolidos amino sustituidas

Country Status (19)

Country Link
US (2) US7718621B2 (cg-RX-API-DMAC7.html)
EP (1) EP1824870A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008519788A (cg-RX-API-DMAC7.html)
KR (1) KR20070085919A (cg-RX-API-DMAC7.html)
CN (1) CN101098881A (cg-RX-API-DMAC7.html)
AR (1) AR053311A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005303961A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0517792A (cg-RX-API-DMAC7.html)
CA (1) CA2587413A1 (cg-RX-API-DMAC7.html)
GB (1) GB0424959D0 (cg-RX-API-DMAC7.html)
IL (1) IL182978A0 (cg-RX-API-DMAC7.html)
MA (1) MA29213B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007005776A (cg-RX-API-DMAC7.html)
NO (1) NO20072939L (cg-RX-API-DMAC7.html)
PE (1) PE20061137A1 (cg-RX-API-DMAC7.html)
RU (1) RU2007121581A (cg-RX-API-DMAC7.html)
TW (1) TW200630378A (cg-RX-API-DMAC7.html)
WO (1) WO2006050942A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200703603B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2801100A1 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Macrolides and processes for their preparation
EP1879904A1 (en) * 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. 4" amino linked macrolides useful for the treatment of microbial infections
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP1951735A1 (en) * 2005-11-09 2008-08-06 Glaxo Group Limited New 4*-substituted erythromycin derivative
EP2201010B1 (en) 2007-09-14 2013-11-06 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
CN102223794B (zh) 2008-10-24 2017-12-22 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
CN105198944B (zh) * 2010-05-20 2018-06-01 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
WO2014145210A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN106589023A (zh) * 2016-11-22 2017-04-26 宜昌东阳光药业股份有限公司 一种罗红霉素杂质及其合成方法
JP7344125B2 (ja) 2017-03-30 2023-09-13 エフ. ホフマン-ラ ロシュ アーゲー 細菌感染の治療及び予防のための新規ピリド[2,3-b]インドール化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
KR20070085919A (ko) 2007-08-27
AU2005303961A1 (en) 2006-05-18
ZA200703603B (en) 2008-07-30
CA2587413A1 (en) 2006-05-18
GB0424959D0 (en) 2004-12-15
EP1824870A1 (en) 2007-08-29
US20080090773A1 (en) 2008-04-17
US20080269146A1 (en) 2008-10-30
MA29213B1 (fr) 2008-02-01
RU2007121581A (ru) 2008-12-20
AR053311A1 (es) 2007-05-02
IL182978A0 (en) 2007-08-19
CN101098881A (zh) 2008-01-02
WO2006050942A1 (en) 2006-05-18
US7718621B2 (en) 2010-05-18
TW200630378A (en) 2006-09-01
BRPI0517792A (pt) 2008-10-21
NO20072939L (no) 2007-08-08
JP2008519788A (ja) 2008-06-12
MX2007005776A (es) 2007-07-16

Similar Documents

Publication Publication Date Title
PE20061137A1 (es) Compuestos derivados de macrolidos amino sustituidas
US8524738B2 (en) Quinolinones and quinoxalinones as antibacterial composition
NZ623574A (en) Ketolide compounds
PH12019502042A1 (en) Fungicidal composition and method for controlling plant diseases
GB0011944D0 (en) Organic compounds
JP2010511667A5 (cg-RX-API-DMAC7.html)
NZ594675A (en) Actagardine derivatives
CA2744756A1 (en) Monocarbams and their use as antibacterial agent
TW200745034A (en) New compounds
PE20140649A1 (es) Derivado de macrolido sustituido en la posicion c4
NZ596628A (en) Ketolide compounds having antimicrobial activity
UA101305C2 (ru) Антибактериальные производные хинолина
TW200621694A (en) Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds
MX2010002932A (es) Macrolidos de biarilo con puente en 6, 11.
PE20050582A1 (es) Derivados de quinolona como agentes antibacterianos
JO2725B1 (en) Quinoline antibacterial derivatives
HRP20100384T1 (hr) Antibakterijski derivati kvinolina
MX2009009074A (es) Macrolidos basados en eritromicina.
JO2970B1 (en) Quinoline antibacterial derivatives
JP2010511670A5 (cg-RX-API-DMAC7.html)
WO2002081437A3 (en) Novel n-p-propargyloxyphenethyl-thioacetic acid amides
UA101307C2 (ru) Антибактериальные производные хинолина
Foroumadi et al. Synthesis and in‐vitro antibacterial activity of new N‐substituted piperazinyl quinolones
PE20110161A1 (es) 3-cianopirrolidinil-fenil-oxazolidinonas como agentes antibacterianos
WO2008032204A8 (en) Substituted pyridylmethyl bicyclocarboxyamide compounds

Legal Events

Date Code Title Description
FC Refusal